Co-trimoxazole-sensitive, methicillin-resistant Staphylococcus aureus, Israel, 1988-1997

Jihad Bishara*, Silvio Pitlik, Zmira Samra, Itzhak Levy, Mical Paul, Leonard Leibovici

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


Among bloodstream methicillin-resistant Staphylococcus aureus (MRSA) isolates from adult patients in a single hospital, susceptibility to co-trimoxazole increased progressively from 31% in 1988 to 92% in 1997 (p<0.0001). If also observed in other institutions, these findings should encourage the performance of a clinical trial of sufficient size to compare co-trimoxazole to vancomycin in treating MRSA infections.

Original languageEnglish
Pages (from-to)1168-1169
Number of pages2
JournalEmerging Infectious Diseases
Issue number9
StatePublished - 1 Sep 2003
Externally publishedYes


Dive into the research topics of 'Co-trimoxazole-sensitive, methicillin-resistant Staphylococcus aureus, Israel, 1988-1997'. Together they form a unique fingerprint.

Cite this